2026/2027 Elite Test
Bank: Nursing Care of
the Patient with
Obstetric and
Postpartum
Hemorrhage
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Panic Button" Cheat Sheet
● PART II: THE ELITE TEST BANK
○ Section 1: Foundational Syntax & Application (Questions 1–15) Focus: WHO
2026 E-MOTIVE criteria, QBL mathematics, baseline pharmacology, and Relias
Core Definitions.
○ Section 2: Professional Simulation (Questions 16–40) Focus: Rapid-fire clinical
execution, TexasAIM staging, Jada System deployment, and logistical crisis
management.
○ Section 3: Grandmaster Synthesis (Questions 41–66) Focus: Amniotic Fluid
Embolism (A-GL protocol), Disseminated Intravascular Coagulation (DIC), ROTEM
, application, and multi-system cascading failures.
PART I: THE PRIMER
Mastering obstetric hemorrhage is not an academic exercise; it is the definitive mechanism
standing between a mother's life and catastrophic, preventable mortality. Professional intuition
forged in this domain dictates whether you will successfully halt a hemodynamic collapse using
2026/2027 precision algorithms, or if you will lose the patient to archaic visual estimation.
The "Panic Button" Cheat Sheet:
● The 2026 WHO 300mL Redline: The "wait for 500mL" era is dead. Clinically significant
PPH is now triggered at 300 mL Quantitative Blood Loss (QBL) if accompanied by any
abnormal vital sign.
● The E-MOTIVE Simultaneous Mandate: Sequential treatments are obsolete.
Interventions (Massage, Oxytocic, TXA, IV fluids, Exam, Escalation) must be deployed
concurrently.
● The QBL Absolute Law: 1 gram of weight = 1 milliliter of blood. Visual estimation (EBL)
is strictly prohibited.
● Pharmacological Hard-Stops: Never give Methylergonovine to a hypertensive patient.
Never give Carboprost to an asthmatic patient.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application
Q1: According to the 2026 World Health Organization (WHO) and ACOG guidelines, a client
with a cumulative postpartum blood loss of 350 mL exhibits a heart rate of 115 bpm and a blood
pressure of 90/55 mmHg. Which action is the IMMEDIATE PRIORITY for the practitioner? A)
Continue active management of the third stage of labor and reassess the client when blood loss
reaches the 500 mL threshold. B) Activate the E-MOTIVE treatment bundle simultaneously to
initiate rapid hemorrhage control. C) Document the findings as expected physiological
transitioning and increase the rate of the primary intravenous fluids. D) Sequentially administer
a second-line uterotonic and observe the client's response for 15 minutes before further
intervention.
● The Answer: B (Activate the E-MOTIVE treatment bundle simultaneously to initiate rapid
hemorrhage control.)
● Distractor Analysis:
○ A is incorrect: The 2026 standards eradicated the strict "wait for 500 mL" rule. Blood
loss ≥300 mL combined with an abnormal vital sign is an immediate PPH trigger.
○ C is incorrect: Tachycardia and hypotension are late signs of shock, not normal
transition.
○ D is incorrect: The WHO specifically condemns sequential treatment. Interventions
must be bundled and executed concurrently.
The Mentor's Analysis: The architectural shift in 2026 obstetric care focuses on
time-to-treatment. Because pregnant women have increased blood volume, their vital signs do
not deteriorate until massive volume is lost. The 300 mL redline coupled with tachycardia is a
pre-terminal warning. Professional Intuition: Never wait for the standard 500 mL threshold if
the patient's hemodynamics are already failing. Execute the bundle.
, Q2: A nurse is performing Quantitative Blood Loss (QBL) measurement following a vaginal
delivery. The dry weight of the vaginal drape is 100 grams. The blood-soaked drape weighs 650
grams. The nurse noted 150 mL of amniotic fluid in the under-buttocks drape prior to the
delivery of the placenta. What is the MOST ACCURATE QBL? A) 650 mL B) 550 mL C) 400 mL
D) 700 mL
● The Answer: C (400 mL)
● Distractor Analysis:
○ A is incorrect: This ignores both the dry weight of the drape and the amniotic fluid
volume.
○ B is incorrect: This subtracts the dry weight but fails to account for the pre-placental
amniotic fluid.
○ D is incorrect: You subtract, not add, dry weights and extraneous fluids.
The Mentor's Analysis: QBL is a strict mathematical law: 1 gram equals 1 milliliter. To find the
true blood volume, you must isolate the blood from the environment. Total Weight (650g) - Dry
Weight (100g) = 550g of total fluid. Total Fluid (550mL) - Amniotic Fluid (150mL) = 400 mL true
blood loss. Professional Intuition: Subtract the environment (dry items) and the diluent
(amniotic fluid) to find the absolute truth of the hemorrhage.
Q3: The WHO's E-MOTIVE bundle mandates the simultaneous execution of specific clinical
interventions. Which of the following is EXCLUDED from the initial first-response bundle? A)
Administration of Tranexamic Acid (TXA). B) Initiation of continuous bimanual uterine
compression. C) Administration of oxytocic medications. D) Aggressive uterine fundal massage.
● The Answer: B (Initiation of continuous bimanual uterine compression.)
● Distractor Analysis:
○ A, C, and D are incorrect: These are core, immediate components of the E-MOTIVE
bundle (Massage, Oxytocic, TXA, IV fluids, Exam/Escalation).
○ B is correct: Bimanual compression is a secondary, refractory intervention utilized
during the "Escalation" phase if the initial MOTIVE bundle fails.
The Mentor's Analysis: The MOTIVE acronym is designed to be executable by frontline staff
instantly. Bimanual compression requires a provider to place a fist inside the vaginal vault
against the anterior fornix—a highly invasive maneuver reserved for refractory atony when the
first-line bundle fails. Professional Intuition: Do not jump to highly invasive provider-level
maneuvers before maximizing the non-invasive pharmacological and mechanical baseline.
Q4: A client experiencing a severe postpartum hemorrhage secondary to uterine atony is
prescribed Methylergonovine. The practitioner must IMMEDIATELY withhold this medication
and request an alternative if the client's electronic health record reveals a history of: A) Chronic
severe asthma. B) Preeclampsia with severe features. C) Type 1 Diabetes Mellitus. D) Von
Willebrand disease.
● The Answer: B (Preeclampsia with severe features.)
● Distractor Analysis:
○ A is incorrect: Asthma is the absolute contraindication for Carboprost (Hemabate),
not Methylergonovine.
○ C is incorrect: Diabetes does not contraindicate Methylergonovine.
○ D is incorrect: Von Willebrand disease is a coagulopathy. Uterotonics are still
indicated to control the mechanical tone.
The Mentor's Analysis: Methylergonovine is a potent ergot alkaloid that causes severe,
sustained systemic vasoconstriction. In a patient with preeclampsia—a disease pathology
characterized by profound endothelial vasospasm and hypertension—administering this drug
will rapidly induce an acute hypertensive crisis, leading directly to hemorrhagic stroke.
Bank: Nursing Care of
the Patient with
Obstetric and
Postpartum
Hemorrhage
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Panic Button" Cheat Sheet
● PART II: THE ELITE TEST BANK
○ Section 1: Foundational Syntax & Application (Questions 1–15) Focus: WHO
2026 E-MOTIVE criteria, QBL mathematics, baseline pharmacology, and Relias
Core Definitions.
○ Section 2: Professional Simulation (Questions 16–40) Focus: Rapid-fire clinical
execution, TexasAIM staging, Jada System deployment, and logistical crisis
management.
○ Section 3: Grandmaster Synthesis (Questions 41–66) Focus: Amniotic Fluid
Embolism (A-GL protocol), Disseminated Intravascular Coagulation (DIC), ROTEM
, application, and multi-system cascading failures.
PART I: THE PRIMER
Mastering obstetric hemorrhage is not an academic exercise; it is the definitive mechanism
standing between a mother's life and catastrophic, preventable mortality. Professional intuition
forged in this domain dictates whether you will successfully halt a hemodynamic collapse using
2026/2027 precision algorithms, or if you will lose the patient to archaic visual estimation.
The "Panic Button" Cheat Sheet:
● The 2026 WHO 300mL Redline: The "wait for 500mL" era is dead. Clinically significant
PPH is now triggered at 300 mL Quantitative Blood Loss (QBL) if accompanied by any
abnormal vital sign.
● The E-MOTIVE Simultaneous Mandate: Sequential treatments are obsolete.
Interventions (Massage, Oxytocic, TXA, IV fluids, Exam, Escalation) must be deployed
concurrently.
● The QBL Absolute Law: 1 gram of weight = 1 milliliter of blood. Visual estimation (EBL)
is strictly prohibited.
● Pharmacological Hard-Stops: Never give Methylergonovine to a hypertensive patient.
Never give Carboprost to an asthmatic patient.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application
Q1: According to the 2026 World Health Organization (WHO) and ACOG guidelines, a client
with a cumulative postpartum blood loss of 350 mL exhibits a heart rate of 115 bpm and a blood
pressure of 90/55 mmHg. Which action is the IMMEDIATE PRIORITY for the practitioner? A)
Continue active management of the third stage of labor and reassess the client when blood loss
reaches the 500 mL threshold. B) Activate the E-MOTIVE treatment bundle simultaneously to
initiate rapid hemorrhage control. C) Document the findings as expected physiological
transitioning and increase the rate of the primary intravenous fluids. D) Sequentially administer
a second-line uterotonic and observe the client's response for 15 minutes before further
intervention.
● The Answer: B (Activate the E-MOTIVE treatment bundle simultaneously to initiate rapid
hemorrhage control.)
● Distractor Analysis:
○ A is incorrect: The 2026 standards eradicated the strict "wait for 500 mL" rule. Blood
loss ≥300 mL combined with an abnormal vital sign is an immediate PPH trigger.
○ C is incorrect: Tachycardia and hypotension are late signs of shock, not normal
transition.
○ D is incorrect: The WHO specifically condemns sequential treatment. Interventions
must be bundled and executed concurrently.
The Mentor's Analysis: The architectural shift in 2026 obstetric care focuses on
time-to-treatment. Because pregnant women have increased blood volume, their vital signs do
not deteriorate until massive volume is lost. The 300 mL redline coupled with tachycardia is a
pre-terminal warning. Professional Intuition: Never wait for the standard 500 mL threshold if
the patient's hemodynamics are already failing. Execute the bundle.
, Q2: A nurse is performing Quantitative Blood Loss (QBL) measurement following a vaginal
delivery. The dry weight of the vaginal drape is 100 grams. The blood-soaked drape weighs 650
grams. The nurse noted 150 mL of amniotic fluid in the under-buttocks drape prior to the
delivery of the placenta. What is the MOST ACCURATE QBL? A) 650 mL B) 550 mL C) 400 mL
D) 700 mL
● The Answer: C (400 mL)
● Distractor Analysis:
○ A is incorrect: This ignores both the dry weight of the drape and the amniotic fluid
volume.
○ B is incorrect: This subtracts the dry weight but fails to account for the pre-placental
amniotic fluid.
○ D is incorrect: You subtract, not add, dry weights and extraneous fluids.
The Mentor's Analysis: QBL is a strict mathematical law: 1 gram equals 1 milliliter. To find the
true blood volume, you must isolate the blood from the environment. Total Weight (650g) - Dry
Weight (100g) = 550g of total fluid. Total Fluid (550mL) - Amniotic Fluid (150mL) = 400 mL true
blood loss. Professional Intuition: Subtract the environment (dry items) and the diluent
(amniotic fluid) to find the absolute truth of the hemorrhage.
Q3: The WHO's E-MOTIVE bundle mandates the simultaneous execution of specific clinical
interventions. Which of the following is EXCLUDED from the initial first-response bundle? A)
Administration of Tranexamic Acid (TXA). B) Initiation of continuous bimanual uterine
compression. C) Administration of oxytocic medications. D) Aggressive uterine fundal massage.
● The Answer: B (Initiation of continuous bimanual uterine compression.)
● Distractor Analysis:
○ A, C, and D are incorrect: These are core, immediate components of the E-MOTIVE
bundle (Massage, Oxytocic, TXA, IV fluids, Exam/Escalation).
○ B is correct: Bimanual compression is a secondary, refractory intervention utilized
during the "Escalation" phase if the initial MOTIVE bundle fails.
The Mentor's Analysis: The MOTIVE acronym is designed to be executable by frontline staff
instantly. Bimanual compression requires a provider to place a fist inside the vaginal vault
against the anterior fornix—a highly invasive maneuver reserved for refractory atony when the
first-line bundle fails. Professional Intuition: Do not jump to highly invasive provider-level
maneuvers before maximizing the non-invasive pharmacological and mechanical baseline.
Q4: A client experiencing a severe postpartum hemorrhage secondary to uterine atony is
prescribed Methylergonovine. The practitioner must IMMEDIATELY withhold this medication
and request an alternative if the client's electronic health record reveals a history of: A) Chronic
severe asthma. B) Preeclampsia with severe features. C) Type 1 Diabetes Mellitus. D) Von
Willebrand disease.
● The Answer: B (Preeclampsia with severe features.)
● Distractor Analysis:
○ A is incorrect: Asthma is the absolute contraindication for Carboprost (Hemabate),
not Methylergonovine.
○ C is incorrect: Diabetes does not contraindicate Methylergonovine.
○ D is incorrect: Von Willebrand disease is a coagulopathy. Uterotonics are still
indicated to control the mechanical tone.
The Mentor's Analysis: Methylergonovine is a potent ergot alkaloid that causes severe,
sustained systemic vasoconstriction. In a patient with preeclampsia—a disease pathology
characterized by profound endothelial vasospasm and hypertension—administering this drug
will rapidly induce an acute hypertensive crisis, leading directly to hemorrhagic stroke.
